IP Library Granted Patent US 9,359,601
Granted Patent B2
US 9,359,601 · App. 13/147,910 · Granted Jun 7, 2016

Methods of creating and screening DNA-encoded libraries

Inventor: Richard W. Wagner (Cambridge, MA)
Assignee: X-Chem, Inc.
C12N15/1068C12N15/1065C40B40/08C40B50/06C40B70/00C07H21/00C40B40/04C40B40/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,359,601
App. No.
13/147,910
Granted
Jun 7, 2016
Kind
B2
Abstract

The present invention features a number of methods for identifying one or more compounds that bind to a biological target. The methods include synthesizing a library of compounds, wherein the compounds contain a functional moiety having one or more diversity positions. The functional moiety of the compounds is operatively linked to an initiator oligonucleotide that identifies the structure of the functional moiety.

Claims (32)

1. A method of tagging DNA-encoded chemical libraries, said method comprising:

(a) binding a first functional group of a bifunctional linker to a component of said chemical library, wherein said component comprises a functional moiety,

(b) binding a second functional group of a bifunctional linker to an initiator oligonucleotide at the 5′ end of said initiator oligonucleotide, and

(c) binding an identifier region at the 3′ end of said initiator oligonucleotide,

wherein said initiator oligonucleotide is modified to increase solubility of a member of said DNA-encoded chemical library in organic conditions,

wherein said modified initiator oligonucleotide comprises a nucleotide having a hydrophobic moiety, and said hydrophobic moiety is an aliphatic chain at the C5 position.

2. A method of tagging DNA-encoded chemical libraries, said method comprising:

(a) binding a first functional group of a bifunctional linker to a component of said chemical library, wherein said component comprises a functional moiety,

(b) binding a second functional group of a bifunctional linker to an initiator oligonucleotide at the 5′ end of said initiator oligonucleotide, and

(c) binding an identifier region at the 3′ end of said initiator oligonucleotide,

wherein said initiator oligonucleotide is modified to increase solubility of a member of said DNA-encoded chemical library in organic conditions,

wherein said modified initiator oligonucleotide comprises an insertion having a hydrophobic moiety, and said hydrophobic moiety is an azobenzene.

3. The method of claim 1 , wherein said initiator oligonucleotide bound to said bifunctional linker forms a hairpin structure.

4. The method of claim 2 , wherein said initiator oligonucleotide bound to said bifunctional linker forms a hairpin structure.

5. The method of claim 1 , wherein said initiator oligonucleotide comprises an identifier region.

6. The method of claim 5 , wherein said identifier region of step (c) hybridizes to said identifier region of said initiator oligonucleotide.

7. The method of claim 2 , wherein said initiator oligonucleotide comprises an identifier region.

8. The method of claim 7 , wherein said identifier region of step (c) hybridizes to said identifier region of said initiator oligonucleotide.

9. The method of claim 1 , wherein said bifunctional linker is modified to increase solubility of a member of said DNA-encoded chemical library in organic conditions.

10. The method of claim 9 , wherein the modified bifunctional linker comprises one or more of an alkyl chain, a polyethylene glycol unit, a branched species with positive charges, or a hydrophobic ring structure.

11. The method of claim 10 , wherein the modified bifunctional linker comprises 12 to 45 polyethylene glycol units.

12. The method of claim 2 , wherein said bifunctional linker is modified to increase solubility of a member of said DNA-encoded chemical library in organic conditions.

13. The method of claim 12 , wherein the modified bifunctional linker comprises one or more of an alkyl chain, a polyethylene glycol unit, a branched species with positive charges, or a hydrophobic ring structure.

14. The method of claim 13 , wherein the modified bifunctional linker comprises 12 to 45 polyethylene glycol units.

15. The method of claim 1 , wherein said identifier region of step (c) or identifier region of said initiator oligonucleotide is modified to increase solubility of a member of said DNA-encoded chemical library in organic conditions.

16. The method of claim 2 , wherein said identifier region of step (c) or identifier region of said initiator oligonucleotide is modified to increase solubility of a member of said DNA-encoded chemical library in organic conditions.

17. The method of claim 1 , wherein said identifier region of step (c) encodes said functional moiety.

18. The method of claim 2 , wherein said identifier region of step (c) encodes said functional moiety.

19. The method of claim 1 , wherein prior to step (c) the method comprises linking a chemical building block to said functional moiety and said identifier region of step (c) encodes said chemical building block.

20. The method of claim 2 , wherein prior to step (c) the method comprises linking a chemical building block to said functional moiety and said identifier region of step (c) encodes said chemical building block.

21. The method of claim 1 , wherein said member of said DNA-encoded chemical library has an octanol:water coefficient from 1.0 to 2.5.

22. The method of claim 2 , wherein said member of said DNA-encoded chemical library has an octanol:water coefficient from 1.0 to 2.5.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 15, 2021
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
To: JAGUAR HOLDING COMPANY I; JAGUAR HOLDING COMPANY II; PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
Reel/Frame 054931/0201 →
SECURITY INTEREST Recorded Dec 11, 2020
From: X-CHEM, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 054619/0407 →
RELEASE OF SECURITY INTEREST Recorded Jan 20, 2016
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
To: X-CHEM, INC.
Reel/Frame 037534/0983 →
SECURITY AGREEMENT Recorded Sep 2, 2015
From: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC; PPD DEVELOPMENT, L.P.; PHARMACO INVESTEMENTS, INC.; X-CHEM, INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS COLLATERAL AGENT
Reel/Frame 036528/0004 →
RELEASE OF SECURITY INTEREST Recorded Sep 2, 2015
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
To: PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC; PPD DEVELOPMENT, L.P.; PHARMACO INVESTEMENTS, INC.; X-CHEM, INC.
Reel/Frame 036481/0051 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT SUPPLEMENT Recorded Jun 12, 2015
From: X-CHEM, INC.
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT
Reel/Frame 035900/0365 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2011
From: WAGNER, RICHARD W.
To: X-CHEM, INC.
Reel/Frame 027100/0787 →
Continuity (2)
Provisional Application 61152508 · Feb 13, 2009
Related Publication 20120053091A1 · Mar 1, 2012